Platelet-rich plasma improves impaired glucose hemostasis, disrupted insulin secretion, and pancreatic oxidative stress in streptozotocin-induced diabetic rat

Growth Factors
Marzieh ZarinMarzieh Nemati

Abstract

Our study aimed to investigate the effects of platelet-rich plasma (PRP) on impaired glucose homeostasis, disrupted islet insulin secretion, and pancreatic oxidative status in streptozotocin (STZ)-diabetic rats. A total of 64 Sprague-Dawley male were randomized to four groups including controls, diabetes, control-PRP, and diabetes-PRP. The rats received the PRP (0.5 ml/kg, SC injection) twice weekly for 4 weeks. Plasma glucose and insulin levels, pancreatic oxidative stress markers and islet insulin secretion and content were measured. Compared with the control group, in the diabetic group, increased plasma glucose and malondialdehyde (MDA) levels and decreased plasma insulin level, islet insulin secretion, pancreatic superoxide dismutase (SOD), and catalase activities were observed. PRP treatment significantly reduced plasma glucose and MDA levels and enhanced plasma insulin, antioxidant enzyme activity, islet insulin secretion, and content in the diabetic rats. These findings showed that PRP can improve pancreatic islet insulin secretion, pancreatic oxidative stress and regulate plasma insulin and glucose levels in diabetic rats.

References

Sep 10, 2005·Reviews in Endocrine & Metabolic Disorders·Rohit N Kulkarni
Nov 1, 2005·Cytokine & Growth Factor Reviews·Sushil G RaneHuei-Min Lin
Mar 15, 2006·Lancet·Denis Daneman
Dec 7, 2007·Journal of Cellular and Molecular Medicine·H Y LeeS H Ryu
May 17, 2008·Biochemical Society Transactions·Päivi MiettinenTimo Otonkoski
May 6, 2009·International Journal of Dental Hygiene·S RajaP Pudakalkatti
Jan 29, 2010·Diabetes Care·UNKNOWN American Diabetes Association
Dec 18, 2010·Free Radical Biology & Medicine·Justin L Rains, Sushil K Jain
Jul 12, 2011·Current Pharmaceutical Biotechnology·Peter A M EvertsIgnace H J T de Hingh
Aug 4, 2011·Clinical Chemistry and Laboratory Medicine : CCLM·Hui YangSheng-Kai Yan
Dec 25, 2013·Journal of Diabetes and Metabolic Disorders·Chinedum Ogbonnaya EleazuUdeme Nelson Essien
Mar 7, 2014·Cell & Bioscience·Hanan Alismail, Sha Jin
Apr 8, 2014·International Journal of Hepatology·Zahra HesamiAkbar Vahdati
Feb 18, 2015·PM & R : the Journal of Injury, Function, and Rehabilitation·Lawrence P LaiBoqing Chen
Feb 28, 2015·Journal of Cutaneous and Aesthetic Surgery·Rachita Dhurat, Ms Sukesh
Apr 22, 2015·World Journal of Diabetes·Surapon Tangvarasittichai
Jun 13, 2015·Oxidative Medicine and Cellular Longevity·Kenneth Maiese
Jul 22, 2015·Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur̈ Transfusionsmedizin Und Immunham̈atologie·Atul Sonker, Anju Dubey
Jan 1, 2013·Journal of Biomarkers·Brahm Kumar TiwariSyed Ibrahim Rizvi
Jan 7, 2016·Proceedings of the National Academy of Sciences of the United States of America·Mingfeng ZhangDefu Zeng
Jul 10, 2018·Clinical and Experimental Reproductive Medicine·Ayman Shehata Dawood, Hesham Abdelaziz Salem

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.